BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18712898)

  • 1. Bacterial RNase P RNA is a drug target for aminoglycoside-arginine conjugates.
    Berchanski A; Lapidot A
    Bioconjug Chem; 2008 Sep; 19(9):1896-906. PubMed ID: 18712898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bacterial RNase P RNA as a drug target.
    Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy.
    Lapidot A; Vijayabaskar V; Litovchick A; Yu J; James TL
    FEBS Lett; 2004 Nov; 577(3):415-21. PubMed ID: 15556620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of inhibition of bacterial ribonuclease P by aminoglycoside derivatives.
    Kawamoto SA; Sudhahar CG; Hatfield CL; Sun J; Behrman EJ; Gopalan V
    Nucleic Acids Res; 2008 Feb; 36(2):697-704. PubMed ID: 18084035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
    Hegde R; Borkow G; Berchanski A; Lapidot A
    FEBS J; 2007 Dec; 274(24):6523-36. PubMed ID: 18028446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcription.
    Lapidot A; Berchanski A; Borkow G
    FEBS J; 2008 Nov; 275(21):5236-57. PubMed ID: 18803669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense inhibition of Escherichia coli RNase P RNA: mechanistic aspects.
    Gruegelsiepe H; Willkomm DK; Goudinakis O; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1049-56. PubMed ID: 14523923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of bacterial RNase P by aminoglycoside-arginine conjugates.
    Eubank TD; Biswas R; Jovanovic M; Litovchick A; Lapidot A; Gopalan V
    FEBS Lett; 2002 Jan; 511(1-3):107-12. PubMed ID: 11821058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein synthesis by aminoglycoside-arginine conjugates.
    Carriere M; Vijayabaskar V; Applefield D; Harvey I; Garneau P; Lorsch J; Lapidot A; Pelletier J
    RNA; 2002 Oct; 8(10):1267-79. PubMed ID: 12403465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step.
    Borkow G; Vijayabaskar V; Lara HH; Kalinkovich A; Lapidot A
    Antiviral Res; 2003 Nov; 60(3):181-92. PubMed ID: 14638394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The precursor tRNA 3'-CCA interaction with Escherichia coli RNase P RNA is essential for catalysis by RNase P in vivo.
    Wegscheid B; Hartmann RK
    RNA; 2006 Dec; 12(12):2135-48. PubMed ID: 17135488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the archaeal ribonuclease P proteins from Pyrococcus horikoshii OT3.
    Terada A; Honda T; Fukuhara H; Hada K; Kimura M
    J Biochem; 2006 Aug; 140(2):293-8. PubMed ID: 16829535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNase P of the Cyanophora paradoxa cyanelle: a plastid ribozyme.
    Li D; Willkomm DK; Schön A; Hartmann RK
    Biochimie; 2007 Dec; 89(12):1528-38. PubMed ID: 17881113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking of cationic antibiotics to negatively charged pockets in RNA folds.
    Hermann T; Westhof E
    J Med Chem; 1999 Apr; 42(7):1250-61. PubMed ID: 10197968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neamine dimers targeting the HIV-1 TAR RNA.
    Riguet E; Désiré J; Boden O; Ludwig V; Göbel M; Bailly C; Décout JL
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4651-5. PubMed ID: 16153833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of poly(A) polymerase by aminoglycosides.
    Thuresson AC; Kirsebom LA; Virtanen A
    Biochimie; 2007 Oct; 89(10):1221-7. PubMed ID: 17629605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational constraint as a means for understanding RNA-aminoglycoside specificity.
    Blount KF; Zhao F; Hermann T; Tor Y
    J Am Chem Soc; 2005 Jul; 127(27):9818-29. PubMed ID: 15998086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial RNase P as a potential target for novel anti-infectives.
    Eder PS; Hatfield C; Vioque A; Gopalan V
    Curr Opin Investig Drugs; 2003 Aug; 4(8):937-43. PubMed ID: 14508877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.